FOXO3 and cancer: These results demonstrate that FOXO3a strikingly influences the physiological control of βIII-tubulin, at least in part, by the ubiquitin-proteome system, which can potentially modulate cross-resistance to 5-FU in PTX-resistant cancer cells.